Mangoceuticals (MGRX) Total Non-Current Liabilities (2022 - 2026)

Mangoceuticals' Total Non-Current Liabilities history runs 4 years deep, the most recent figure standing at $236965.0 for Q1 2026.

• In Q1 2026, Total Non-Current Liabilities changed N/A year-over-year to $236965.0; the TTM figure through Mar 2026 stood at $236965.0 (changed N/A YoY), while the FY2023 annual figure was $64961.0, down 49.52% from the prior year.
• Total Non-Current Liabilities came in at $236965.0 for Q1 2026 at Mangoceuticals, up from $12167.0 in the prior quarter.
• In the past five years, Total Non-Current Liabilities ranged from a high of $236965.0 in Q1 2026 to a low of $12167.0 in Q3 2024.
• A 4-year average of $90307.7 and a median of $81508.0 in 2023 frame the typical range for Total Non-Current Liabilities.
• Across the five-year window, Total Non-Current Liabilities tumbled 49.52% in 2023 and sank 85.07% in 2024, its largest moves.
• Mangoceuticals' Total Non-Current Liabilities stood at $128680.0 in 2022, then sank by 49.52% to $64961.0 in 2023, then tumbled by 81.27% to $12167.0 in 2024, then soared by 1847.6% to $236965.0 in 2026.
• According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $236965.0, $12167.0, and $30117.0 for Q1 2026, Q3 2024, and Q2 2024 respectively.

Peer Comparison